CVRx Inc (CVRX)

NASDAQ
Currency in USD
5.86
+0.03(+0.51%)
Closed·
After Hours
5.58-0.28(-4.78%)
·
CVRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CVRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.775.97
52 wk Range
4.3018.55
Key Statistics
Edit
Prev. Close
5.83
Open
5.84
Day's Range
5.77-5.97
52 wk Range
4.3-18.55
Volume
203.75K
Average Vol. (3m)
426.03K
1-Year Change
-45.84%
Book Value / Share
2.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.00
Upside
+87.71%
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings upwards for the upcoming period

CVRx Inc News & Analysis

Show more

CVRx Inc Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

CVRx Inc SWOT Analysis


Analyst Outlook
Discover why analysts remain optimistic about CVRx's long-term prospects, with price targets ranging from $14 to $23, despite short-term challenges.
Market Expansion
Learn how CVRx is increasing its market presence, with 227 active implanting centers and strategic adjustments to sales territories for optimized growth.
Financial Pulse
Despite recent revenue shortfalls, CVRx maintains robust gross margins of 83.75% and achieved 30.53% revenue growth over the last twelve months.
Barostim Breakthrough
Explore CVRx's innovative heart failure treatment, Barostim, and its potential to revolutionize the $3.7 billion HFrEF market with impressive clinical outcomes.
Read full SWOT analysis

CVRx Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of -$0.53 beats forecast, revenue of $12.3M misses expectations; stock drops 8.74% after hours to $7.10
  • Revenue up 15% YoY, driven by 14% US growth; heart failure segment revenue rises from $9.7M to $11.1M
  • Full-year 2025 revenue guidance set at $55M-$58M; Q2 2025 revenue expected between $13M-$14M
  • Company plans sales territory expansion, considers large-scale clinical trial costing $20M-$25M over 5-7 years
  • CEO emphasizes long-term growth strategy; CFO focuses on strategic hiring and sales force realignment
Last Updated: 05/08/2025, 05:41 PM
Read Full Transcript

Compare CVRX to Peers and Sector

Metrics to compare
CVRX
Peers
Sector
Relationship
P/E Ratio
−3.0x−5.4x−0.5x
PEG Ratio
−0.23−0.100.00
Price / Book
2.2x4.7x2.6x
Price / LTM Sales
2.9x3.2x3.0x
Upside (Analyst Target)
96.2%53.7%52.4%
Fair Value Upside
Unlock−3.2%8.7%Unlock

Analyst Ratings

6 Buy
0 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 11.00
(+87.71% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.53 / -0.54
Revenue / Forecast
12.30M / 14.68M
EPS Revisions
Last 90 days

CVRX Income Statement

People Also Watch

1.1500
SKYX
-2.54%
43.70
BILL
+2.41%
60.38
SKY
-0.26%
8.43
RGNX
-1.63%

FAQ

What Is the CVRx (CVRX) Stock Price Today?

The CVRx stock price today is 5.86

What Stock Exchange Does CVRx Trade On?

CVRx is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for CVRx?

The stock symbol for CVRx is "CVRX."

What Is the CVRx Market Cap?

As of today, CVRx market cap is 152.79M.

What Is CVRx's Earnings Per Share (TTM)?

The CVRx EPS (TTM) is -2.17.

When Is the Next CVRx Earnings Date?

CVRx will release its next earnings report on Aug 05, 2025.

From a Technical Analysis Perspective, Is CVRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CVRx Stock Split?

CVRx has split 0 times.

How Many Employees Does CVRx Have?

CVRx has 206 employees.

What is the current trading status of CVRx (CVRX)?

As of Jun 22, 2025, CVRx (CVRX) is trading at a price of 5.86, with a previous close of 5.83. The stock has fluctuated within a day range of 5.77 to 5.97, while its 52-week range spans from 4.30 to 18.55.

What Is CVRx (CVRX) Price Target According to Analysts?

The average 12-month price target for CVRx is USD11, with a high estimate of USD14 and a low estimate of USD7. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +87.71% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.